InvestorsHub Logo
Followers 81
Posts 1964
Boards Moderated 0
Alias Born 11/12/2003

Re: None

Thursday, 09/04/2014 3:30:11 PM

Thursday, September 04, 2014 3:30:11 PM

Post# of 30990
The Good News about the McDonnell Trial...

is it's over. The former management is gone and the current management is technically competent and they are focused on bringing a pharmaceutical version of Anatabine to market. Regardless of what you think of the former management, they discovered something that will change healthcare in the US. The current management should now be able to educate the pharmaceutical industry and eventually bring this to market. I wish them all the success in the world.

One of these days, the market will understand the miracles of anatabine.

Here's a link worth reading carefully....

http://www.wnem.com/story/16000127/anatabloc-a-solution-to-chronic-pain

excerpts...

Dr. Wilson explains further, "Anatabloc turns that chronic low grade inflammation off. That's why people with Crohn's disease, fibromyalgia show a marked response. From what I have been doing clinically, from what I've seen, that's one of its most effective areas.

"Alzheimer's disease, Parkinson's disease, autism, epilepsy, schizophrenia - things that we never before had any idea what the etiology of the disease could be. Heart disease, diabetes, arthritis, inflammatory disease of the bowels like Crohn's disease, [the list goes] on and on. And one of the most intriguing deceases is fibromyalgia," said Dr. Wilson.


JMHO,

NJ

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.